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24 The Journal of Thoracic and Cardiobjectives: The potential role of glycine in combination with standard lung pres-
rvation with low-potassium dextran solution in lung ischemia-reperfusion injury
as not been investigated in a preclinical porcine transplant model.
ethods: In a control group (n  6), donor lungs were flushed with 1 liter of
ow-potassium dextran solution. In a second group (LPD-glyc, n  6), low-
otassium dextran solution was supplemented with 3.75 g of glycine. In a third
roup (IV-glyc, n  6), donor preconditioning was performed by intravenous
dministration of 3.75 g glycine 1 hour before low-potassium dextran preservation.
rafts were stored in low-potassium dextran at 4°C for 24 hours. Posttransplant
raft function was assessed throughout a 7-hour observation period.
esults: In the control group, 2 recipients died of right-sided heart failure caused by
evere ischemia-reperfusion injury. All animals of the glycine groups survived the
ntire observation period. Pulmonary vascular resistance remained significantly (P
.01) lower in both glycine groups when compared with controls. At the end of the
bservation period pulmonary vascular resistance in the control group was higher (P
.01) compared with the glycine groups (1310  319 dyn  sec  cm5 vs 879
127 dyn sec cm5 [LPD-glyc] vs 663 191 dyn sec cm5 [IV-glyc]).
hanges of lung tissue water content were lower in the IV-glyc group compared
ith the LPD-control (P  .01) and LPD-glyc lungs (P  .05). Oxygenation
PO2/FIO2) was higher in the IV-glyc group compared with the LPD-glyc and control
ungs (445  110 mm Hg vs 388  124 mm Hg [P  .01] vs 341  224 mm Hg
P  .001], respectively).
iscussion: Modification of low-potassium dextran solution with glycine or donor
reconditioning ameliorates ischemia-reperfusion injury in lung transplantation.
his intriguing approach merits further evaluation with respect to the mechanisms
nvolved and may improve results in clinical lung preservation.
schemia-reperfusion (I/R) injury is a major contributor to early graft failure after
lung transplantation.1 The clinical consequences of I/R injury include prolonged
ventilatory requirements, requirement for high FIO2, and pulmonary edema.2 An
nderstanding of the pathophysiology of I/R injury is evolving, and the following
echanisms play a role: cytokine production, neutrophil activation, free radical
eneration, lipid peroxidation, and decreased number of endogenous free radical
cavengers.3,4 The therapeutic or preventive approach to I/R injury has been
esigned to directly counter these pathologic processes (eg, antitumor necrosis
actor- antibodies)5 or to augment defense systems with the addition of novel
gents (eg, calcium channel blockers)6or endogenously produced substances (eg,
vascular Surgery ● March 2006
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TXuperoxide dismutase).7 Many of these treatments have
esulted in prolonged lung preservation with good posttrans-
lantation graft function in experimental models, but the
limination of I/R injury in clinical lung transplantation still
emains a challenge, especially with regard to prolonged
schemic times or the consideration of marginal donor lungs
or transplantation.
Our approach to ameliorating I/R injury uses glycine, a
onessential amino acid. Glycine is nontoxic and has been
hown to protect proximal tubules and hepatocytes from
ypoxia8 and surgical manipulation after donor intravenous
IV) pretreatment.9 Glycine also prevents nephrotoxicity
aused by cyclosporine A.10 Furthermore, glycine added to
graft rinse solution reduced reperfusion injury and im-
roved initial graft function and survival after liver trans-
lantation.11 Moreover, glycine improved the hepatic mi-
rocirculation and reduced liver injury in a low-flow, reflow
erfusion model.12
Glycine has not been investigated in lung transplantation.
he mechanism, however, by which glycine exerts its pro-
ective effect in the liver is controversial and likely com-
lex. Many have held glycine, which is an amino acid
omponent of glutathione, as an example of a free radical
cavenger.13 Zhang and colleagues14 showed inhibition of
upffer cells in the liver graft by glycine.14 The underlying
echanisms here are provided by Wheeler and associates,10
ho reported that glycine can activate the glycine-depen-
ent chloride channel, which causes chloride inflow. This
tself leads to a superpolarization of the cell membrane and
onsequently inhibits the openness of potential dependent
alcium channels, thus inhibiting the activation of Kupffer
ells and, ultimately, the release of proinflammatory cyto-
ines.10 In a study on hepatocyte serum-free cryopreserva-
ion, Muller and colleagues15 impressively demonstrated
hat glycine improved the viability of cryopreserved porcine
epatocytes by preventing damage of the genomic DNA
eading to improved recovery of living cells to approxi-
ately 55% of the initial cell number after thawing. In that
tudy, glycine was added to both the thawing and the
reezing solution. In another study, Schemmer and col-
eagues16 applied glycine to human liver preservation and
howed reduced I/R injury after transplantation.
In this study, we hypothesized that (1) the addition of
lycine to the lung flush preservation solution and (2) IV
onor pretreatment with glycine would both improve lung
raft function after 24 hours of cold ischemic preservation
Abbreviations and Acronyms
I/R  ischemia-reperfusion
LPD low-potassium dextran
PVR pulmonary vascular resistancend transplantation in a preclinical large animal model. m
The Journal of Thoracicaterials and Methods
he purpose of this study was to evaluate initial lung function after
4 hours of cold ischemic preservation with low-potassium dex-
ran (LPD) or glycine-enriched LPD solution (LPD-glyc) followed
y a 7-hour observational reperfusion period. In addition, we
ested the effect of IV donor pretreatment with glycine (IV-glyc) 1
our before lung retrieval on posttransplant graft function after 24
ours of cold ischemic preservation. The results in these 2 study
roups were compared with a control group in which lungs were
ushed with and stored for 24 hours in LPD and then transplanted.
nimal Care
ll animals received humane care in compliance with the “Prin-
iples of Laboratory Animal Care” and the “Guide for the Care of
aboratory Animals” prepared by the Institute of Laboratory An-
mal Resources, National Research Council, and published by the
ational Academy Press, revised 1996. The study was reviewed
nd all experiments were approved by the local ethics committee
f the Hannover Medical School, Hannover, Germany.
onor Procedure
n all 18 donor animals (female pigs, German Landrace, 25-35 kg),
nesthesia was induced by the application of azaperone (5 mg/kg),
tropine (5 mg total dose, intramuscular), and pentobarbital (1
g/kg, IV). Animals were intubated and ventilated in a pressure-
ontrolled mode with a peak inspiratory pressure of 30 cm H2O, a
ositive end-expiratory pressure of 5 cm H2O, and an FIO2 of 0.5.
nesthesia was maintained by continuous infusion of pentobarbi-
al (5 mg · kg · h) and fentanyl (1 mg · kg · h). After median
ternotomy, the inferior and superior venae cavae were encircled
ith ties and the pulmonary artery was dissected from the ascend-
ng aorta. After systemic application of heparin (300 IU/kg), a
-mm cannula was inserted into the pulmonary artery. Right-sided
eart inflow occlusion was performed, and the left atrial appendage
as excised. The pulmonary artery was clamped, and either 1 liter
f 4°C cold LPD solution (Perfadex, Vitrolife, Gothenburg, Swe-
en) supplemented with 0.3 mL Tris-buffer (control group and
V-glyc group) or 1 liter of LPD solution supplemented with 3.75 g
f glycine (LPD-glyc) plus 0.7 to 1.1 mL Tris-buffer was infused.
he pH of the preservation solution was adjusted using Tris-buffer
o a target level of 7.5. The intrapulmonary artery pressure was
ecorded throughout the entire flushing period. A mean perfusion
ressure of 16 mm Hg was maintained. The harvested lungs were
tored in a semi-inflated state in LPD at 4°C for 24 hours.
orcine Single Lung Transplantation
ix transplant procedures were performed in each of the 3 study
roups. In all 18 recipient animals (female pigs, German Landrace,
5-36 kg) anesthesia was induced and maintained as described
bove. Recipient arterial pressure was monitored by a carotid
rtery catheter, and pulmonary artery hemodynamics were moni-
ored by a Swan-Ganz catheter (7.5 F, Baxter Healthcare, Irvine,
alif). Cardiac output and extravascular lung water were recorded
sing a femoral artery thermodilution catheter connected to the
ardiac output recording device (PiCCO Systems, Pulsion Medical
ystems AG, Munich, Germany). The chest was entered through a
eft lateral thoracotomy in the fourth intercostal space. Left pul-
onary artery, lung veins, and bronchus were dissected. After
and Cardiovascular Surgery ● Volume 131, Number 3 725
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TXystemic administration of heparin (300 IU/kg), a left-sided pneu-
onectomy was performed. The graft was transplanted using
unning polypropylene sutures for all 3 anastomoses. After 10
inutes of reperfusion the right pulmonary artery and right main
ronchus were crossclamped through the left-sided thoracotomy.
ssessment of Hemodynamics and Lung Function
n all experiments, atrial, systemic arterial, and pulmonary arterial
ressures were recorded online. Dynamic lung compliance was
onitored continuously with a modified ventilator (Dräger, Lü-
eck, Germany). Arterial blood gas analysis was performed after
lacement of catheters and every 30 minutes during the reperfu-
ion period. At these intervals, pulmonary vascular resistance
PVR) was calculated after measurement of cardiac output with the
ransfemoral thermodilution catheter, which was connected to the
ardiac index computer (PiCCO Systems). After calibration by
njection of cold 0.9% saline solution into the jugular vein, the
ystem calculated the cardiac index online by pressure curve
nalysis. By means of the same thermal bolus injection that was
istributed into intravascular blood volume and extravascular lung
ater, the extravascular lung water index (arithmetic value divided
y body weight in kilograms) was computed.
et-to-Dry Lung Weight Ratios
fter flush perfusion, immediately before cold ischemic storage, a
 4-cm biopsy was taken from the lower segments of the upper
obe of the right donor lung to avoid damage to the graft before
torage and transplantation. The wet-to-dry ratio of that biopsy was
onsidered as the baseline measure of the prestorage lung water
ontent. At the end of the 7-hour reperfusion period the lingula of
he transplanted lung was resected and used for the wet-to-dry ratio
alculation. All specimens were taken at the same site of the right
ative donor lung or the pulmonary grafts to achieve the most
omparable conditions. All biopsies were weighed and then placed
n an oven at 100°C for 72 hours. After this drying procedure, the
ortion was reweighed and the ratio of the weight before and after
rying was calculated. This measure reflects lung water or pulmo-
ary edema.
tatistical Analysis
ll data are expressed as mean  standard deviation. Continuous
ata were analyzed by repeated-measures analysis of variance. For
ata without repeated measurement, analysis of variance was ap-
lied. Data obtained from the 2 animals that died during the
bservation period were included in statistical analyses up to the
oint at which death occurred. All data were analyzed with SPSS
oftware (SPSS for MS Windows, version 11.5; SPSS Inc, Chi-
ago, Ill).
esults
onor and recipient pigs were matched for size in each
tudy group. The mean baseline PaO2 levels in arterial blood
n donor animals before retrieval in each group were not
ifferent. Two of the 6 recipient animals in the control
roup died during the reperfusion period from severe right-
ided heart failure at 2 and 4.5 hours after initiation of o
26 The Journal of Thoracic and Cardiovascular Surgery ● Marceperfusion. All 12 animals in the 2 glycine groups survived
or the entire observation period.
Assessment of Posttransplantation Lung Function and
schemia-Reperfusion Injury
Glycine as an additive to low-potassium dextran pres-
rvation solution versus low-potassium dextran. After
ompletion of the 7-hour reperfusion period, a favorable
rend toward higher FIO2/PaO2 ratios was seen in the LPD-
lyc group (388  124 mm Hg) compared with the control
roup (341  224 mm Hg, P  .05) (Figure 1). PVR was
ignificantly lower in the glycine group throughout the
bservational period than in the control cohort (P  .01).
igure 2 illustrates the changes in PVR with time in the
PD-glyc and control groups. Before termination of the
xperiment, PVR was significantly higher in the IV-glyc
ontrol (control) group compared with the LPD-glyc group
ith 1310  319 dyn  sec  cm5 vs 879  127 dyn 
ec  cm5 (P  .01). The mean pulmonary arterial pres-
ure was also significantly lower in the LPD-glyc group
ompared with control lungs (Figure 3) (P  .01). As
entioned above, to evaluate the content of lung water at
he end of the reperfusion period reflecting postreperfusion
ulmonary edema, wet-to-dry weight ratios were calculated.
fter 7 hours of reperfusion, wet-to-dry ratios were signif-
cantly lower in LPD-glyc lungs (7.0  0.5) compared with
ontrol lungs (10.1  0.8), representing less fluid accumu-
ation over the posttransplant reperfusion period (P  .05).
he cardiac output was also significantly higher in the
PD-glyc group over time compared with control animals
P  .01). Systemic vascular resistance, systemic arterial
lood pressure, and extravasal lung water content were not
tatistically different between groups; however, a trend to-
ard a lower extravasal lung water content (P  .06) was
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igure 1. PaO2/FIO2 ratios in group comparison. Open triangles,
ntravenous glycin; open circles, glycin; open circles, control.bserved in the LPD-glyc group.
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TXGlycine for intravenous donor pretreatment versus low-
otassium dextran. Compared with control lungs, the IV-
lyc group showed significantly higher FIO2/PaO2 ratios
341  224 mm Hg vs 445  110 mm Hg, respectively; P
 .001) (Figure 1). As in the LPD-glyc group, the PVR was
ignificantly lower in the IV-glyc group throughout the
bservational period compared with the control cohort (P
01) (Figure 2). Also, before the end of the reperfusion
eriod, the PVR was significantly higher in the IV-glyc
control) group (1310  319 dyn  sec  cm5 vs 663 
91 dyn  sec  cm5) (P  .01). In addition, wet-to-dry
ung weight ratios were significantly lower at the end of the
eperfusion period in the IV-glyc group than in the control
roup (P  .01). The mean pulmonary artery pressure was
lso significantly lower in the IV-glyc group compared with
ontrol lungs (Figure 3) (P  .01). The cardiac output was
lso significantly higher in the IV-glyc group over time
ompared with control animals (P  .01). Again, systemic
ascular resistance, systemic arterial blood pressure, and
xtravasal lung water content were not statistically different
etween groups; however, a lower extravasal lung water
ontent (P  .06) was observed in the IV-glyc group.
Intravenous glycine donor pretreatment is superior to
lycine supplementation of the flush preservation solu-
ion. When the 2 glycine study groups were compared
tatistically, significantly higher FIO2/PaO2 ratios were seen
n the IV-glyc group (445  110 mm Hg vs 388  124 mm
g, respectively; P  .001) (Figure 1). PVR was signifi-
antly lower in the IV-glyc group throughout the observa-
ional period than in the LPD-glyc cohort (P  .01) (Figure
). Wet-to-dry lung weight ratios were not statistically dif-
erent between the 2 groups (LPD-glyc 7.0 0.5 vs IV-glyc
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igure 2. Changes in PVR in study groups throughout graft reper-
usion (P < .05: LPD-glyc and IV-glyc vs LPD). Open triangles,
ntravenous glycin; open circles, glycin; open circles, control..3  0.3). The mean pulmonary artery pressure, however, c
The Journal of Thoracicas significantly lower in the IV-glyc group compared with
PD-glyc lungs (Figure 3) (P  .05). The cardiac output
as also significantly higher in the IV-glyc group over time
ompared with LPD-glyc animals (P  .01). Systemic
ascular resistance, systemic arterial blood pressure, and
xtravasal lung water content were not statistically different
etween the 2 study groups.
iscussion
e used our well-established and previously described pre-
linical porcine single lung transplantation model of I/R
njury17 to evaluate the protective effects of glycine as an
dditive to the preservation solution or as donor IV pretreat-
ent. We found that the addition of glycine to the pulmo-
ary flush solution during cold ischemia resulted in im-
roved oxygenation, reduced PVR, and reduced pulmonary
rtery pressures and wet-to-dry weight ratios measured after
4 hours of cold storage and 7 hours of reperfusion when
ompared with LPD preserved lungs. IV donor pretreatment
ith glycine, however, was superior over the supplementa-
ion of glycine to the flush solution.
The mechanism by which glycine exerted these protec-
ive physiologic effects remains elusive and will be further
nvestigated in ongoing studies in our laboratories including
urfactant function analysis.
This model has proven useful to study interventions to
rotect against I/R injury after lung transplantation.17 We
reserved the lungs for an extended period of 24 hours to
nsure that we had sufficiently severely injured lungs. We
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igure 3. Changes in mean pulmonary artery pressure in study
roups during reperfusion (P < .05, LPD-glyc vs all other groups).
pen triangles, Intravenous glycin; open circles, glycin; open
ircles, control.hose to examine the severity of the I/R injury 7 hours after
and Cardiovascular Surgery ● Volume 131, Number 3 727
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TXhe start of reperfusion because this corresponds to a time in
he clinical setting when we frequently see evidence of this
njurious process.
Glycine was selected because it has been shown in other
odels of I/R injury, mainly after liver transplantation, to
mprove functional and biochemical measures when added
o the flush solution.14,16 Barros-Schelotto and colleagues18
ave proven glycine to reduce post-liver transplant I/R
njury in porcine grafts retrieved from non–heart-beating
onors.18 Moreover, Schemmer and associates19 reported
hat IV glycine administration improves survival in rat liver
ransplantation. We chose LPD as our preservation solution
ecause it has become the current clinical and experimental
tandard of lung preservation for transplantation
orldwide.20,21
Glycine has been shown to have a wide range of activ-
ties, and it is likely that its ability to improve graft function
fter I/R injury is the result of one of these other mecha-
isms. Bogdanova and coworkers13 were able to show the
bility of glycine to scavenge free oxygen radicals in hepa-
ocytes. In their study, treatment of hepatocytes with mer-
aptopropionyl glycine, a scavenger of OH*, abolished
ypoxia-induced inhibition of the Na/K adenosine
riphosphatase. Also, some centers, including our own pro-
ram, now use glutathione-based preservation solutions.
lutathione is a potential oxygen free radical scavenger. We
reviously showed that Celsior, a low-potassium glutathione-
ased preservation solution, led to comparable outcome in a
orcine single lung transplant model of I/R injury when com-
ared with LPD.22 However, PVR and neutrophil sequestra-
ion were both significantly reduced in the Celsior group in this
revious study. Glycine is an amino acid component of gluta-
hione and therefore exerts its action as an oxygen free radical
cavenger.
Others have shown that glycine is protective in I/R injury
odels of liver transplantation because of its ability to
rotect the graft from brain death-related injury when the
onor was pretreated with glycine.14 The underlying mech-
nism was the inhibition of Kupffer cells by glycine. In that
tudy they also demonstrated with electron microscopy that
he inhibition of glycine by strychnine led to severe injury
f the graft. Wheeler and colleagues10 reported that on a
ubcellular level glycine activates glycine-dependent chlo-
ide channels, which causes chloride inflow into the cell
eading to superpolarization of the cellular membrane. As a
onsequence, the openness of potential dependent calcium
hannels is inhibited and proinflammatory cytokine release
s reduced. In a study on cryopreserved hepatocytes, Muller
nd collaborators15 determined that glycine improved the
iability of cryopreserved porcine hepatocytes by prevent-
ng damage of the genomic DNA. Thereby, glycine im-
roved the recovery of living hepatocytes to approximately
5% of the initial cell number after thawing. Southard and s
28 The Journal of Thoracic and Cardiovascular Surgery ● Marcolleagues demonstrated improved viability of human hepa-
ocytes when glycine was added to both the freezing and the
hawing solution in another cryopreservational study, as
eported by Muller and colleagues.15 Especially in liver
ransplantation, it is well known that surgical organ manip-
lation during harvest significantly harms the organ. Once
gain, Schemmer and colleagues23 were able to show that
onor pretreatment with glycine totally prevented the ef-
ects of organ manipulation on survival and enzyme release.
n another study by Schemmer and colleagues,9 using the rat
iver transplantation model, IV donor pretreatment im-
roved survival after transplantation.
In this study, we noted no systemic hemodynamic dif-
erences (diastolic and systolic blood pressures) between the
roups. This suggests that glycine added to the preservation
olution, as well as IV donor pretreatment, did not affect
ystemic arterial hemodynamics. However, a significant re-
uction in pulmonary artery pressure and PVR, and in-
reases in cardiac output were seen, which may support a
ocal regulatory effect of glycine in the pulmonary vascu-
ature. The answer to why IV pretreatment with glycine is
uperior to supplementation of the flush solution remains
lusive. However, with regard to the potential action of
lycine in organ preservation and thereby in consideration
f the evidence in the literature, it can be speculated that the
onor IV pretreatment with glycine inhibits injurious mech-
nisms of brain death to the lung, which would not be
ossible if the drug is administered only at the time of
ushing. This is supported by Zhang and colleagues,14 who
eported less graft injury after transplantation of livers from
rain-dead donor animals. However, this is certainly not the
echanism of action in this study, because only lungs from
ealthy, non–brain-dead donor animals were transplanted.
onclusion
e showed that glycine either in the flush preservation
olution or as IV donor pretreatment in a porcine single lung
ransplant model decreased the severity of I/R injury after
4 hours of cold ischemic preservation and 7 hours of
eperfusion. This is primarily represented by improved ox-
genation and decreased pulmonary artery pressure, PVR,
nd posttransplant pulmonary edema. We were unable to
scertain which mechanism was responsible for the benefi-
ial effects seen. Future studies at our program will include
he effect of glycine on the preservation of surfactant func-
ion and the role of glycine on injurious mechanisms of
rain death to the transplanted lung. Our ultimate goal is to
e able to apply this simple modification of lung preserva-
ion solutions or the IV pre-retrieval donor treatment with
lycine to the clinical setting to improve lung function after
ransplantation.
The authors thank Ms. Petra Oppelt, who reviewed the
tatistical analysis in this study as a professional biostatis-
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